• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的血压控制:来自德国慢性肾脏病(GCKD)研究的横断面分析。

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.

机构信息

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Department of Nephrology and Hypertension, Klinikum Nürnberg, Paracelsus Private Medical University, Nürnberg, Germany.

出版信息

PLoS One. 2018 Aug 20;13(8):e0202604. doi: 10.1371/journal.pone.0202604. eCollection 2018.

DOI:10.1371/journal.pone.0202604
PMID:30125326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6101389/
Abstract

We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30-60 mL/min/1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use.

摘要

我们评估了德国肾病科护理下中度慢性肾病(CKD)患者的高血压患病率、知晓率、治疗率和控制率。在德国慢性肾脏病(GCKD)研究中,2010 年至 2012 年期间,在一项前瞻性观察性队列研究中,招募了 5217 名接受肾病专家护理的患者。纳入标准为估算肾小球滤过率(eGFR)为 30-60mL/min/1.73m2 或 eGFR>60mL/min/1.73m2 时存在显性蛋白尿。由经过培训的研究人员以标准化方式测量诊室血压,并在标准化访谈中评估高血压知晓率和药物治疗情况。如果收缩压<140mmHg 且舒张压<90mmHg,则认为血压得到控制。在可获得测量值的 5183 名患者中,平均血压为 139.5±20.4/79.3±11.8mmHg;4985 名(96.2%)患者患有高血压。知晓率和治疗率均>90%。然而,仅有 2456 名(49.3%)高血压患者血压得到控制。约一半(51.0%)血压未得到控制的患者符合难治性高血压标准。多变量分析中与血压控制较好相关的因素包括年龄较小、女性、收入较高、低或无蛋白尿以及使用某些类别的降压药物。我们得出结论,即使在肾病科专家护理的情况下,CKD 患者的血压控制仍然具有挑战性,尽管知晓率和药物使用率较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/3ea916d6a906/pone.0202604.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/4113d7b06cd3/pone.0202604.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/30801258c7b3/pone.0202604.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/fda20ea737a1/pone.0202604.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/07c3f6145d6f/pone.0202604.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/3ea916d6a906/pone.0202604.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/4113d7b06cd3/pone.0202604.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/30801258c7b3/pone.0202604.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/fda20ea737a1/pone.0202604.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/07c3f6145d6f/pone.0202604.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dec/6101389/3ea916d6a906/pone.0202604.g005.jpg

相似文献

1
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.慢性肾脏病中的血压控制:来自德国慢性肾脏病(GCKD)研究的横断面分析。
PLoS One. 2018 Aug 20;13(8):e0202604. doi: 10.1371/journal.pone.0202604. eCollection 2018.
2
Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.转诊的中度慢性肾脏病患者的疾病负担和风险特征:德国慢性肾脏病(GCKD)队列的构成。
Nephrol Dial Transplant. 2015 Mar;30(3):441-51. doi: 10.1093/ndt/gfu294. Epub 2014 Sep 30.
3
Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).中国慢性肾脏病成人高血压控制情况:中国慢性肾脏病队列研究(C-STRIDE)的基线结果。
Am J Hypertens. 2018 Mar 10;31(4):486-494. doi: 10.1093/ajh/hpx222.
4
Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study.一大群慢性肾脏病患者中痛风的患病率及其相关因素:德国慢性肾脏病(GCKD)研究
Nephrol Dial Transplant. 2015 Apr;30(4):613-21. doi: 10.1093/ndt/gfu352. Epub 2014 Nov 13.
5
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.澳大利亚昆士兰州非透析慢性肾病高血压患者的血压管理。
BMC Nephrol. 2019 Sep 4;20(1):348. doi: 10.1186/s12882-019-1532-6.
6
Prevalence and risk factors of chronic kidney disease in newly diagnosed and untreated hypertensive patients in cameroon: A cross-sectional study.喀麦隆新诊断且未治疗的高血压患者慢性肾脏病的患病率及危险因素:一项横断面研究
Saudi J Kidney Dis Transpl. 2017 Sep-Oct;28(5):1144-1149. doi: 10.4103/1319-2442.215143.
7
Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania.立陶宛家庭医疗患者中慢性肾病的患病率及其风险因素。
Clin Nephrol. 2012 Sep;78(3):198-206.
8
Hypertension control and antihypertensive therapy in patients with chronic kidney disease.慢性肾脏病患者的高血压控制与抗高血压治疗
Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.
9
Blood pressure control and kidney damage in hypertension: Results of a three-center cross-sectional study in North Central Nigeria.高血压患者的血压控制与肾损害:尼日利亚中北部一项三中心横断面研究的结果
Niger J Clin Pract. 2020 Nov;23(11):1590-1597. doi: 10.4103/njcp.njcp_271_20.
10
Blood Pressure Control During Chronic Kidney Disease Progression.慢性肾脏病进展过程中的血压控制
Am J Hypertens. 2017 Jun 1;30(6):610-616. doi: 10.1093/ajh/hpx017.

引用本文的文献

1
Management and treatment of chronic kidney disease in the Danish Lolland-Falster Health Study: focus on renoprotection and cardiovascular disease prevention.丹麦洛兰-法尔斯特健康研究中慢性肾脏病的管理与治疗:聚焦肾脏保护和心血管疾病预防
Clin Kidney J. 2025 Aug 1;18(9):sfaf242. doi: 10.1093/ckj/sfaf242. eCollection 2025 Sep.
2
Impact of Improved Diagnosis and Treatment on Holistic CKD Burden.改善诊断与治疗对慢性肾脏病整体负担的影响。
Kidney Int Rep. 2025 Jun 6;10(8):2608-2620. doi: 10.1016/j.ekir.2025.05.039. eCollection 2025 Aug.
3
Sex-specific differences in the efficacy of renal denervation in patients with resistant hypertension depending on visceral obesity and kidney function.

本文引用的文献

1
How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD?收缩压干预试验(SPRINT)如何指导慢性肾脏病的高血压治疗目标?
Am J Kidney Dis. 2016 Jul;68(1):15-8. doi: 10.1053/j.ajkd.2016.02.045. Epub 2016 Mar 22.
2
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.慢性肾脏病中的隐匿性高血压和夜间血压升高:患病率及其与靶器官损害的关联
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):642-52. doi: 10.2215/CJN.08530815. Epub 2016 Feb 18.
3
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
根据内脏肥胖和肾功能情况,顽固性高血压患者肾去神经支配疗效的性别差异。
Front Cardiovasc Med. 2025 Jan 30;12:1501296. doi: 10.3389/fcvm.2025.1501296. eCollection 2025.
4
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing.社区居住的慢性肾脏病老年成年人高血压的患病率、知晓率、治疗率及控制率:爱尔兰老龄化纵向研究
Clin Kidney J. 2024 Jun 27;17(8):sfae184. doi: 10.1093/ckj/sfae184. eCollection 2024 Aug.
5
Managing cardiovascular risk factors in patients with chronic kidney disease: pharmacological and non-pharmacological interventions in the Copenhagen CKD Cohort.慢性肾脏病患者心血管危险因素的管理:哥本哈根慢性肾脏病队列中的药物和非药物干预措施
Clin Kidney J. 2024 Jun 13;17(7):sfae158. doi: 10.1093/ckj/sfae158. eCollection 2024 Jul.
6
Minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial): study protocol for a multicentre, stepped-wedge, cluster-randomised controlled trial.慢性肾脏病住院患者透析风险最小化(MinDial)研究方案:一项多中心、阶梯式、群组随机对照试验的研究方案。
Trials. 2024 Jun 7;25(1):368. doi: 10.1186/s13063-024-08182-x.
7
Prevalence of chronic kidney disease and associated factors among patients with underlying chronic disease at Dessie Referral Hospital, East Amhara Region, Ethiopia.埃塞俄比亚东阿姆哈拉州德西转诊医院慢性病患者慢性肾脏病的患病率及相关因素
Front Epidemiol. 2023 Jul 18;3:1154522. doi: 10.3389/fepid.2023.1154522. eCollection 2023.
8
Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.慢性肾病患者和非慢性肾病患者肾去神经支配后的血压降低情况。
Clin Kidney J. 2023 Nov 17;17(1):sfad237. doi: 10.1093/ckj/sfad237. eCollection 2024 Jan.
9
Risk factors associated with uncontrolled blood pressure among patients with non-dialysis chronic kidney disease in Vietnam.越南非透析慢性肾脏病患者血压控制不佳的相关危险因素。
Belitung Nurs J. 2021 Oct 28;7(5):370-379. doi: 10.33546/bnj.1611. eCollection 2021.
10
Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study.严重肾小球滤过率降低患者的血压与肾脏结局:一项全国性观察性队列研究。
J Hypertens. 2022 Aug 1;40(8):1487-1498. doi: 10.1097/HJH.0000000000003168. Epub 2022 Jun 21.
慢性肾脏病中貌似治疗抵抗性高血压的患病率及预后意义:慢性肾功能不全队列研究报告
Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.
4
Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.慢性肾脏病患者的高血压管理:一场马拉松,而非短跑。
J Am Soc Nephrol. 2016 Jan;27(1):40-3. doi: 10.1681/ASN.2015101125. Epub 2015 Nov 9.
5
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
6
The double challenge of resistant hypertension and chronic kidney disease.耐药性高血压和慢性肾病的双重挑战。
Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3.
7
Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.美国慢性肾病患者抗高血压药物的使用模式:全国健康与营养检查调查的横断面分析
Clin Ther. 2015 Jan 1;37(1):188-96. doi: 10.1016/j.clinthera.2014.11.011. Epub 2014 Dec 16.
8
Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.转诊的中度慢性肾脏病患者的疾病负担和风险特征:德国慢性肾脏病(GCKD)队列的构成。
Nephrol Dial Transplant. 2015 Mar;30(3):441-51. doi: 10.1093/ndt/gfu294. Epub 2014 Sep 30.
9
Germany: Health system review.德国:卫生系统综述。
Health Syst Transit. 2014;16(2):1-296, xxi.
10
Drug adherence in chronic kidney diseases and dialysis.慢性肾脏病与透析中的药物依从性
Nephrol Dial Transplant. 2015 Jan;30(1):39-44. doi: 10.1093/ndt/gfu015. Epub 2014 Feb 9.